| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:70369 | 6480464 | epigallocatechin gallate results in decreased expression of AQP1 mRNA | CTD | PMID:20706672 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:70369 | 6480464 | epigallocatechin gallate results in increased expression of AQP1 mRNA | CTD | PMID:20706672 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10181 | 6480464 | Ethinyl Estradiol affects the expression of AQP1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10181 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of AQP1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:10181 | 6480464 | Ethinyl Estradiol results in decreased expression of AQP1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of AQP1 mRNA | CTD | PMID:20381596 |
| 2,2,2-tetramine | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of AQP1 protein] | CTD | PMID:19634143 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10181 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of AQP1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10181 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AQP1 mRNA | CTD | PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10181 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of AQP1 mRNA] | CTD | PMID:15667827 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of AQP1 mRNA | CTD | PMID:21346803 |
| 7,12-dimethyltetraphene | decreases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP1 mRNA | CTD | PMID:12376462 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | RGD:70369 | 6480464 | AQP1 mRNA affects the reaction [Uric Acid results in increased secretion of IL1B protein] | CTD | PMID:21051542 |
| acetazolamide | decreases expression | ISO | RGD:70369 | 6480464 | Acetazolamide results in decreased expression of AQP1 protein | CTD | PMID:17219999 |
| aflatoxin B1 | decreases expression | ISO | RGD:10181 | 6480464 | Aflatoxin B1 results in decreased expression of AQP1 mRNA | CTD | PMID:19770486 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of AQP1 mRNA | CTD | PMID:16483693 |
| arsenic atom | multiple interactions | ISO | RGD:10181 | 6480464 | [APOE protein affects the susceptibility to Arsenic] which affects the expression of AQP1 mRNA | CTD | PMID:22719926 |
| arsenite(3-) | decreases expression | ISO | RGD:10181 | 6480464 | arsenite results in decreased expression of AQP1 mRNA | CTD | PMID:18929588 |
| benazepril | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA] | CTD | PMID:11510275 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10181 | 6480464 | Benzo(a)pyrene results in decreased expression of AQP1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10181 | 6480464 | Benzo(a)pyrene results in decreased expression of AQP1 mRNA | CTD | PMID:19770486 PMID:22610609 |
| benzo[a]pyrene | increases expression | ISO | RGD:10181 | 6480464 | Benzo(a)pyrene results in increased expression of AQP1 mRNA | CTD | PMID:22228805 |
| bleomycin A2 | decreases expression | EXP | | 6480464 | Bleomycin results in decreased expression of AQP1 mRNA | CTD | PMID:15782499 |
| capsaicin | increases response to substance | ISO | RGD:10181 | 6480464 | AQP1 results in increased susceptibility to Capsaicin | CTD | PMID:20018876 |
| chlorogenic acid | increases expression | ISO | RGD:70369 | 6480464 | Chlorogenic Acid results in increased expression of AQP1 mRNA | CTD | PMID:20706672 |
| ciglitazone | decreases expression | EXP | | 6480464 | ciglitazone results in decreased expression of AQP1 mRNA | CTD | PMID:22193206 |
| clofibrate | multiple interactions | ISO | RGD:10181 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of AQP1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | ISO | RGD:10181 | 6480464 | Clofibrate results in decreased expression of AQP1 mRNA | CTD | PMID:17585979 |
| copper atom | multiple interactions | ISO | RGD:10181 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AQP1 mRNA | CTD | PMID:15467011 |
| copper(0) | multiple interactions | ISO | RGD:10181 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AQP1 mRNA | CTD | PMID:15467011 |
| corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of AQP1 mRNA | CTD | PMID:15755911 |
| cyclosporin A | decreases expression | ISO | RGD:10181 | 6480464 | Cyclosporine results in decreased expression of AQP1 mRNA | CTD | PMID:19770486 |
| cytarabine | decreases expression | ISO | RGD:70369 | 6480464 | Cytarabine results in decreased expression of AQP1 mRNA | CTD | PMID:21198554 |
| D-glucose | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; more ... | CTD | PMID:11510275 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of AQP1 mRNA | CTD | PMID:11510275 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of AQP1 mRNA | CTD | PMID:17379624 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of AQP1 mRNA | CTD | PMID:18636392 |
| dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of AQP1 mRNA | CTD | PMID:22193206 |
| diprotium oxide | increases transport | ISO | RGD:10181 | 6480464 | AQP1 protein results in increased transport of Water | CTD | PMID:11078688 |
| diprotium oxide | increases transport | ISO | RGD:70369 | 6480464 | AQP1 protein results in increased transport of Water | CTD | PMID:21251984 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of AQP1 mRNA | CTD | PMID:21551480 |
| genistein | decreases expression | ISO | RGD:70369 | 6480464 | Genistein results in decreased expression of AQP1 mRNA | CTD | PMID:20706672 |
| glucose | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; more ... | CTD | PMID:11510275 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of AQP1 mRNA | CTD | PMID:11510275 |
| hydrogen peroxide | affects expression | ISO | RGD:70369 | 6480464 | Hydrogen Peroxide affects the expression of AQP1 mRNA | CTD | PMID:20044591 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of AQP1 mRNA | CTD | PMID:21396975 |
| kojic acid | increases expression | ISO | RGD:70369 | 6480464 | kojic acid results in increased expression of AQP1 mRNA | CTD | PMID:16595896 |
| mercury dichloride | affects activity | ISO | RGD:70369 | 6480464 | Mercuric Chloride affects the activity of AQP1 protein | CTD | PMID:11468359 |
| morphine | increases expression | ISO | RGD:10181 | 6480464 | Morphine results in increased expression of AQP1 mRNA | CTD | PMID:21178816 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of AQP1 mRNA | CTD | PMID:19638242 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of AQP1 mRNA | CTD | PMID:16251485 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of AQP1 mRNA | CTD | PMID:16251485 PMID:18417182 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of AQP1 mRNA | CTD | PMID:18417182 PMID:16251485 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of AQP1 mRNA | CTD | PMID:18636392 |
| p-chloromercuribenzenesulfonic acid | decreases activity | ISO | RGD:70369 | 6480464 | 4-Chloromercuribenzenesulfonate results in decreased activity of AQP1 protein | CTD | PMID:11468359 |
| paracetamol | multiple interactions | ISO | RGD:10181 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of AQP1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:10181 | 6480464 | Acetaminophen affects the expression of AQP1 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:10181 | 6480464 | Paraquat results in increased expression of AQP1 mRNA | CTD | PMID:12595580 |
| phenobarbital | multiple interactions | ISO | RGD:10181 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of AQP1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:10181 | 6480464 | Phenobarbital results in increased expression of AQP1 mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | ISO | RGD:10181 | 6480464 | Phenobarbital results in decreased expression of AQP1 mRNA | CTD | PMID:19482888 |
| progesterone | affects localization | EXP | | 6480464 | Progesterone affects the localization of AQP1 protein | CTD | PMID:16452730 |
| progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estrogens] affects the localization of AQP1 protein | CTD | PMID:16452730 |
| propiconazole | decreases expression | ISO | RGD:10181 | 6480464 | propiconazole results in decreased expression of AQP1 mRNA | CTD | PMID:21278054 |
| prostaglandin E2 | increases response to substance | ISO | RGD:10181 | 6480464 | AQP1 results in increased susceptibility to Dinoprostone | CTD | PMID:20018876 |
| resveratrol | increases expression | ISO | RGD:70369 | 6480464 | resveratrol results in increased expression of AQP1 mRNA | CTD | PMID:20706672 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of AQP1 mRNA | CTD | PMID:21172411 |
| silicon dioxide | increases expression | ISO | RGD:10181 | 6480464 | Silicon Dioxide results in increased expression of AQP1 mRNA | CTD | PMID:19073995 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of AQP1 protein | CTD | PMID:19634143 |
| streptozocin | multiple interactions | EXP | | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of AQP1 protein] | CTD | PMID:19634143 |
| tamoxifen | affects expression | ISO | RGD:10181 | 6480464 | Tamoxifen affects the expression of AQP1 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:70369 | 6480464 | tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of AQP1 mRNA | CTD | PMID:17805973 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of AQP1 mRNA | CTD | PMID:16239168 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of AQP1 mRNA | CTD | PMID:12832660 |
| tetraethylammonium | decreases activity | ISO | RGD:70369 | 6480464 | Tetraethylammonium results in decreased activity of AQP1 protein | CTD | PMID:10779387 |
| tetrathiomolybdate(2-) | decreases expression | ISO | RGD:70369 | 6480464 | tetrathiomolybdate analog results in decreased expression of AQP1 mRNA | CTD | PMID:19323979 |
| thiourea | decreases expression | EXP | | 6480464 | Thiourea results in decreased expression of AQP1 mRNA | CTD | PMID:15248066 |
| trans-resveratrol | increases expression | ISO | RGD:70369 | 6480464 | resveratrol results in increased expression of AQP1 mRNA | CTD | PMID:20706672 |
| urethane | decreases expression | ISO | RGD:10181 | 6480464 | Urethane results in decreased expression of AQP1 mRNA | CTD | PMID:16289808 |
| uric acid | multiple interactions | ISO | RGD:70369 | 6480464 | AQP1 mRNA affects the reaction [Uric Acid results in increased secretion of IL1B protein] | CTD | PMID:21051542 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [Glucose results in increased expression of AQP1 mRNA] | CTD | PMID:11510275 |
| water | increases transport | ISO | RGD:10181 | 6480464 | AQP1 protein results in increased transport of Water | CTD | PMID:11078688 |
| water | increases transport | ISO | RGD:70369 | 6480464 | AQP1 protein results in increased transport of Water | CTD | PMID:21251984 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of AQP1 mRNA | CTD | PMID:17074742 |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of AQP1 mRNA | CTD | PMID:17074742 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of AQP1 mRNA | CTD | PMID:17074742 |